Quantitative Assessment of Autologous Fat Transfer

Launched by UNIVERSITY OF CHICAGO · Mar 26, 2024

Keywords

ClinConnect Summary

This clinical trial is examining the outcomes of a procedure called Autologous Fat Transfer (AFT), which is used for breast or chest wall reconstruction. Essentially, this study aims to see how well this procedure works and how satisfied patients feel about the results. If you are at least 18 years old and are planning to have this type of reconstruction, you might be eligible to participate. However, the study cannot include people who are currently dealing with active cancer, certain serious health conditions, or who cannot undergo an MRI scan due to medical reasons.

Participants in this trial can expect to have their chest and torso photographed and will fill out a questionnaire to share their satisfaction and quality of life after the procedure. In addition to standard 2D photos, researchers will also take 3D images, perform MRI scans, and use ultrasound for research purposes. These assessments will happen both before the procedure and during follow-up visits, which will be scheduled for 3 to 6 months later. Overall, this study aims to gather important information that could help improve care for future patients undergoing similar treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age of 18 years or older
• • Planned autologous fat transfer or fat grafting reconstruction of the breast or chest wall.
• • Able to provide written or electronic informed consent.
• • Able to undergo MRI.
• Exclusion Criteria:
• • Vulnerable subjects (children, prisoners, pregnant women).
• • Patients who have active cancer, metastatic disease, solid organ transplantation / immunosuppression, or autoimmune diseases.
• • Unable to undergo MRI (history of metal contraindication, claustrophobia)